Pittsburgh, PA, United States of America

Kelly Picchione

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kelly Picchione: Innovator in Neurodevelopmental Treatments

Introduction

Kelly Picchione is a prominent inventor based in Pittsburgh, PA, who has made significant contributions to the field of neurodevelopmental diseases. As a dedicated researcher, she has focused on developing innovative methods to treat various disorders affecting pediatric patients.

Latest Patents

Kelly holds a patent for "Methods of use for KV7 channel activators." This patent encompasses compounds and pharmaceutical compositions that include a therapeutically effective amount of such compounds, or pharmaceutically acceptable salts, and a pharmaceutically acceptable excipient. The methods outlined in her patent aim to treat neurodevelopmental diseases or disorders (NDD) and developmental and epileptic encephalopathy (DEE) by administering these compounds to pediatric patients.

Career Highlights

Kelly Picchione is currently associated with Biohaven Therapeutics Ltd., where she continues to advance her research and development efforts. Her work is instrumental in creating effective treatments for children suffering from complex neurological conditions.

Collaborations

Throughout her career, Kelly has collaborated with notable professionals in her field, including Michael E. Bozik and Steven Dworetzky. These partnerships have enhanced her research and contributed to the development of innovative therapeutic solutions.

Conclusion

Kelly Picchione's dedication to advancing treatments for neurodevelopmental disorders showcases her commitment to improving the lives of pediatric patients. Her innovative work and patent contributions are paving the way for future advancements in this critical area of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…